What is Pinnacle Research Group?
Established in 1998 and headquartered in Anniston, Alabama, Pinnacle Research Group operates as a specialized clinical research organization. The firm distinguishes itself through the execution of Phase I-IV clinical trials, with a specific emphasis on early-phase development projects. Their therapeutic focus spans critical medical domains, including obesity, infectious diseases, and rheumatology. With a portfolio exceeding 500 completed trials, the company integrates cutting-edge technology with rigorous safety protocols to serve a broad spectrum of sponsors and contract research organizations. Their facility is uniquely equipped to handle both inpatient and outpatient clinical requirements, positioning them as a vital node in the global healthcare innovation pipeline.
How much funding has Pinnacle Research Group raised?
Pinnacle Research Group has raised a total of $336K across 2 funding rounds:
Debt
$150K
Debt
$186K
Debt (2020): $150K with participation from PPP
Debt (2021): $186K led by PPP
Key Investors in Pinnacle Research Group
PPP
Public-Private Partnership
What's next for Pinnacle Research Group?
With the recent influx of capital, Pinnacle Research Group is well-positioned to expand its clinical trial capacity and enhance its technological infrastructure. The strategic deployment of these funds will likely focus on optimizing patient recruitment pipelines and upgrading diagnostic capabilities to meet the increasing demand for specialized Phase I-IV research. As the company transitions into its next phase of growth, the focus will remain on maintaining its exemplary safety record while scaling operations to accommodate more complex, multi-site global studies. This financial stability provides the necessary runway to pursue long-term partnerships with major pharmaceutical sponsors, further cementing their role as a leader in the clinical research sector.
See full Pinnacle Research Group company page
